# A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

> **NCT03038802** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Vaxine Pty Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **BIOLOGICAL:** Therapeutic hepatitis B vaccine
- **BIOLOGICAL:** Commercial Hepatitis B vaccine

## Key facts

- **NCT ID:** NCT03038802
- **Lead sponsor:** Vaxine Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038802, "A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03038802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*